Get Latest Internet Marketing News, Views and Methods All in One Place: Salesforce CEO: COVID Vaccine Is Biggest Technology Challenge In History

Thursday 1 October 2020

Salesforce CEO: COVID Vaccine Is Biggest Technology Challenge In History

WebProNews
Salesforce CEO: COVID Vaccine Is Biggest Technology Challenge In History

“We have hundreds of new vaccines coming for COVID,” says Salesforce CEO Marc Benioff. “It will be one of the biggest logistical and technology challenges really in the history of the planet. Salesforce is building and delivering now our new Work.com for vaccines. we’re going to rapidly have to be able to determine the wheat from the chaff so that we can have the best vaccines possible. Technology is the key to doing that.”

Marc Benioff, CEO of Salesforce, discusses their new Work.com platform for vaccines which utilizes technology to successfully battle the COVID pandemic:

COVID Vaccine Is Biggest Technology Challenge In History

I hope you got your flu shot. Obviously, the flu shot is a vaccine also. We, of course, have COVID vaccines coming. We are in a situation right now where vaccinations are one of the most important things we can do for public health. We all know that. We have hundreds of new vaccines coming for COVID. It will be one of the biggest logistical and technology challenges really in the history of the planet.

Salesforce is building and delivering now our new Work.com for vaccines. We are extending our super successful Work.com product which has helped so many states, nation-states, and companies succeed during the pandemic. We’re going to make sure this vaccination program is a major success as well.

Technology Is The Key To Determining Best Vaccines

You can already look at amazing organizations here in the United States, states like Texas, cities like Chicago, and many others that we work with for contact tracing. They’re already starting to deploy our vaccination program. This means that they have the ability to manage all the information associated with the vaccine, who’s received the vaccine, and how many vaccinations they’ve had.

Some of these vaccines are going to require multiple boosters. The efficacy of the vaccine. The ability to have the person who’s received the vaccine to self-report. Every vaccine is not going to be the highest of quality. There are going to be an assortment and we’re going to rapidly have to be able to determine the wheat from the chaff so that we can have the best vaccines possible. Technology is the key to doing that.